XBiotech (XBIT) Total Liabilities (2014 - 2026)

XBiotech has reported Total Liabilities for 13 years, with the latest figure at $5.2 million in Q2 2026.

• On a quarterly basis, Total Liabilities fell 7.62% year-over-year to $5.2 million in Q2 2026; TTM through Jun 2026 was $5.2 million, a 7.62% decrease from a year earlier, with the FY2025 full-year figure at $9.7 million, down 42.16% from the prior year.
• Total Liabilities was $5.2 million for Q2 2026 at XBiotech, down from $9.7 million in the prior quarter.
• The five-year high for Total Liabilities was $18.9 million in Q2 2024, with the low at $5.2 million in Q2 2026.
• Average Total Liabilities over 5 years is $9.3 million, with a median of $6.9 million recorded in 2023.
• The sharpest annual moves came in 2024 and 2025: Total Liabilities jumped 256.17% in 2024, then sank 70.2% in 2025.
• Over 5 years, Total Liabilities stood at $5.7 million in 2022, then soared by 36.27% to $7.8 million in 2023, then jumped by 116.57% to $16.8 million in 2024, then slumped by 42.16% to $9.7 million in 2025, then plunged by 46.67% to $5.2 million in 2026.
• The last three Total Liabilities figures came in at $5.2 million (Q2 2026), $9.7 million (Q4 2025), and $5.3 million (Q3 2025), per Business Quant data.